Skip to main content
Publications
Bertelsen RJ, Rava M, Carsin AE Clinical markers of asthma and IgE assessed in parents before conception predict asthma and hayfever in the offspring 10.1111/cea.12906
Zijlema WL, Triguero-Mas M, Smith G, Cirach M, Martinez D The relationship between natural outdoor environments and cognitive functioning and its mediators 10.1016/j.envres.2017.02.017
Marzo-Ortega H, Halliday A, Jugl S, Mokashi S, Porter B, Talloczy Z, Sherif B Impact of alternative definitions of treatment response on long-term efficacy of secukinumab in tumour necrosis factor alpha-naïve patients with active ankylosing spondylitis
Temam S, Burte E, Adam M, Anto JM, Basagana X, Bousquet J, Carsin AE Socioeconomic position and outdoor nitrogen dioxide (NO2) exposure in Western Europe: a multi-city analysis 10.1016/j.envint.2016.12.026
Strober B, Gottlieb AB, Sherif B McLeod L Mordin M Gnanasakthy A Secukinumab sustains early patient-reported outcome benefits through 1 year: results from 2 phase III randomized placebo-controlled clinical trials comparing secukinumab with etanercept 10.1016/j.jaad.2016.11.043
Ensenyat A, Espigares-Tribo G, Machado L, Verdejo FJ, Rodriguez-Arregui R, Serrano J, Miret M, Galindo G, Blanco A, Marsal JR Metabolic risk management, physical exercise and lifestyle counselling in low-active adults: controlled randomized trial (BELLUGAT) 10.1186/s12889-017-4144-8
Triguero-Mas M, Gidlow CJ, Martinez D The effect of randomised exposure to different types of natural outdoor environments compared to exposure to an urban environment on people with indications of psychological distress in Catalonia
Boucher O, Julvez J, Guxens M, Arranz E, Ibarluzea J, Sanchez de Miguel M, Fernandez-Somoano A, Tardon A, Rebagliato M, Garcia-Esteban R Association between breastfeeding duration and cognitive development, autistic traits and ADHD symptoms: a multicenter study in Spain 10.1038/pr.2016.238
Tell-Marti G, Puig-Butille JA, Potrony M, Plana E A common variant in the MC1R gene (p.V92M) is associated with Alzheimer's disease risk 10.3233/JAD-161113
Fernandez-Barres S, Romaguera D, Valvi D, Martinez D Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: the INMA birth cohort study 10.1111/ijpo.12092
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal MDR, Marsal JR Reply: antithrombotic regimen in post-TAVR atrial fibrillation: not an easy decision 10.1016/j.jcin.2016.09.038
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab provides better relief from psoriasis-related pain, itching, and scaling than ustekinumab
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides better relief from quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides better relief from quality-of-life impact than placebo in moderate to severe psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab provides faster and better quality of life impact than ustekinumab in psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab treatment provides more effective relief from patient-reported psoriasis-related pain, itching, and scaling than ustekinumab
Blauvelt A, Korman N, Mollon P, Zhou Y, Milutinovic M, You R, Sherif B Secukinumab treatment provides faster and more effective relief from patient-reported quality of life impact than ustekinumab in subjects with moderate to severe plaque psoriasis
Police RL, Trask PC, Wang J, Olivares R, Khan S Colosia A Njue A Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis 10.1177/1078155215603230
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Vender R, Leonardi C, Puig L, Ziv M, Zhou Y, Gilloteau I, Sherif B McLeod LD Secukinumab provides greater cumulative 52-week skin clearance and quality of life benefit in patients with moderate-to-severe plaque psoriasis than ustekinumab: an area under the curve analysis
Blauvelt A, Mehlis S, Vanaclocha F, Vender R, Zhao Y, Gilloteau I, Davenport E Secukinumab provides greater 52-week sustained relief from dermatology-related quality of life impact on clothing choice and sexual function than ustekinumab
Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA Safety of adding salmeterol to fluticasone propionate in children with asthma 10.1056/NEJMoa1606356
Afonso A, Schmiedl S, Becker C, Tcherny-Lessenot S, Primatesta P, Plana E A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal Mdel R, Marsal JR Warfarin and antiplatelet therapy versus Warfarin alone for treating patients with atrial fibrillation undergoing transcatheter aortic valve replacement 10.1016/j.jcin.2016.06.025
O'Connor G, Pinero Casas M, Basagana X, Vicente ML, Davand P, Torrent M, Martinez-Murciano D Garcia-Esteban R Television viewing duration during childhood and long-association with adolescent neuropsychological outcomes 10.1016/j.pmedr.2016.08.013
Nabhan C, Zhou X Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States 10.1002/ajh.24401
